JP2015503918A5 - - Google Patents

Download PDF

Info

Publication number
JP2015503918A5
JP2015503918A5 JP2014550544A JP2014550544A JP2015503918A5 JP 2015503918 A5 JP2015503918 A5 JP 2015503918A5 JP 2014550544 A JP2014550544 A JP 2014550544A JP 2014550544 A JP2014550544 A JP 2014550544A JP 2015503918 A5 JP2015503918 A5 JP 2015503918A5
Authority
JP
Japan
Prior art keywords
patent document
international
cell
january
literature
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014550544A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015503918A (ja
JP6548897B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/072331 external-priority patent/WO2013102219A1/en
Publication of JP2015503918A publication Critical patent/JP2015503918A/ja
Publication of JP2015503918A5 publication Critical patent/JP2015503918A5/ja
Application granted granted Critical
Publication of JP6548897B2 publication Critical patent/JP6548897B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014550544A 2011-12-30 2012-12-31 同種異系細胞の医療用途の誘導のための方法及び組成物並びに治療的利用 Active JP6548897B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161582070P 2011-12-30 2011-12-30
US61/582,070 2011-12-30
US201261591211P 2012-01-26 2012-01-26
US61/591,211 2012-01-26
PCT/US2012/072331 WO2013102219A1 (en) 2011-12-30 2012-12-31 Methods and compositions for the clinical derivation of an allogenic cell and therapeutic uses

Publications (3)

Publication Number Publication Date
JP2015503918A JP2015503918A (ja) 2015-02-05
JP2015503918A5 true JP2015503918A5 (enExample) 2016-02-18
JP6548897B2 JP6548897B2 (ja) 2019-07-24

Family

ID=48698707

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014550544A Active JP6548897B2 (ja) 2011-12-30 2012-12-31 同種異系細胞の医療用途の誘導のための方法及び組成物並びに治療的利用

Country Status (12)

Country Link
US (8) US9803176B2 (enExample)
EP (2) EP2798058B1 (enExample)
JP (1) JP6548897B2 (enExample)
CA (2) CA3113484A1 (enExample)
DK (1) DK3321355T3 (enExample)
ES (2) ES2890126T3 (enExample)
HR (1) HRP20211373T1 (enExample)
HU (1) HUE056817T2 (enExample)
PL (1) PL3321355T3 (enExample)
PT (1) PT3321355T (enExample)
SI (1) SI3321355T1 (enExample)
WO (1) WO2013102219A1 (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5505760B2 (ja) 2005-09-27 2014-05-28 ティッシュテク・インコーポレーテッド 羊膜調製物及び精製組成物及びその使用方法
US9526770B2 (en) 2011-04-28 2016-12-27 Tissuetech, Inc. Methods of modulating bone remodeling
US9682044B2 (en) 2011-06-10 2017-06-20 Tissuetech, Inc. Methods of processing fetal support tissues, fetal support tissue powder products, and uses thereof
US10167448B2 (en) 2013-12-12 2019-01-01 Samsung Life Public Welfare Foundation Pharmaceutical composition for treating cerebrovascular diseases, containing stem cell-derived exosome as active ingredient
WO2015142061A1 (ko) 2014-03-18 2015-09-24 사회복지법인 삼성생명공익재단 줄기세포 유래 엑소좀을 유효성분으로 포함하는 뇌 염증성 질환의 치료용 조성물
WO2015179711A1 (en) * 2014-05-21 2015-11-26 Mimedx Group, Inc. Micronized wharton's jelly
TW201603818A (zh) 2014-06-03 2016-02-01 組織科技股份有限公司 組成物及方法
EP3167049A4 (en) 2014-07-08 2017-11-29 MIMEDX Group Inc. Micronized wharton's jelly
US20160243288A1 (en) 2015-02-23 2016-08-25 Tissuetech, Inc. Apparatuses and methods for treating ophthalmic diseases and disorders
US10342831B2 (en) 2015-05-20 2019-07-09 Tissuetech, Inc. Composition and methods for preventing the proliferation and epithelial-mesenchymal transition of epithelial cells
JP6648259B2 (ja) * 2015-08-12 2020-02-14 チャ バイオテック カンパニー リミテッド 向上された臍帯由来付着型幹細胞、その製造方法及びその用途
US12551509B2 (en) 2015-11-18 2026-02-17 Lucina Patent Holdco, Llc Acellular regenerative products and methods of their manufacture
TW201733600A (zh) 2016-01-29 2017-10-01 帝聖工業公司 胎兒扶持組織物及使用方法
EP3474869B1 (en) * 2016-06-24 2025-04-09 Osiris Therapeutics, Inc. Human tissue derived compositions and uses thereof
KR102048228B1 (ko) 2016-12-02 2019-11-25 가톨릭대학교 산학협력단 T 세포 자극용 엑소좀 및 이의 약제학적 용도
KR101864234B1 (ko) * 2017-07-04 2018-06-04 인하대학교 산학협력단 음경해면체 유래 엑소좀을 유효성분으로 포함하는, 발기부전 예방, 개선 또는 치료용 조성물
US11285177B2 (en) 2018-01-03 2022-03-29 Globus Medical, Inc. Allografts containing viable cells and methods thereof
CN108239621B (zh) * 2018-01-24 2020-08-18 北京臻溪谷医学研究中心(有限合伙) 一种胎盘亚全能干细胞分离、扩增、冻存、复苏干细胞的方法
EP3911344A4 (en) 2019-01-16 2022-10-19 University of Utah Research Foundation MESENCHYMAL STEM CELL LAYERS FROM HUMAN UMBILICAL CORD AND PROCESS FOR THEIR PRODUCTION
JP7585207B2 (ja) * 2019-01-16 2024-11-18 ユニバーシティ オブ ユタ リサーチ ファウンデーション 子宮瘢痕形成を予防するための間葉系幹細胞シートの使用
JP7717712B2 (ja) * 2020-03-09 2025-08-04 エスエムエスバイオテック インコーポレイテッド 幹細胞組成物および組織を修復する方法
US20230338428A1 (en) * 2020-09-08 2023-10-26 Amit Patel Allogenic umbilical cord stem cells for treating severe respiratory conditions
US20230057957A1 (en) * 2021-08-23 2023-02-23 Therapeutic Solutions International, Inc. Umbilical cord mesenchymal stem cells for treatment of chronic obstructive pulmonary disease and lung degeneration
EP4460697A4 (en) * 2022-01-07 2026-06-24 Mercy Bioanalytics Inc COMPOSITIONS AND METHODS FOR THE DETECTION OF LUNG CANCER
US20230295569A1 (en) * 2022-03-15 2023-09-21 Creative Medical Technologies, Inc. Therapeutic regenerative cells
US20230293598A1 (en) * 2022-03-15 2023-09-21 Narkeshyo LLC Prevention of radiation exposure associated pathology by treatment with umbilical cord derived regenerative cells
US20230364148A1 (en) * 2022-05-12 2023-11-16 Therapeutic Solutions International, Inc. Inhibition and reversion of chronic obstructive pulmonary disease (copd) by endothelial cell regeneration
US20240003871A1 (en) * 2022-06-29 2024-01-04 FUJIFILM Cellular Dynamics, Inc. Ipsc-derived astrocytes and methods of use thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
WO1999061587A1 (en) 1998-05-29 1999-12-02 Osiris Therapeutics, Inc. Human cd45+ and/or fibroblast + mesenchymal stem cells
US20030161818A1 (en) 2002-02-25 2003-08-28 Kansas State University Research Foundation Cultures, products and methods using stem cells
JP4790592B2 (ja) 2003-02-11 2011-10-12 ダビース,ジヨン・イー ヒト臍帯のウォートンジェリーからの前駆細胞
ES2569780T3 (es) 2003-06-27 2016-05-12 DePuy Synthes Products, Inc. Células posparto derivadas de tejido placentario y métodos de preparación y uso de las mismas
NZ553695A (en) * 2004-08-16 2009-10-30 Cellres Corp Pte Ltd Isolation of stem/progenitor cells from amniotic membrane of umbilical cord
WO2007106089A1 (en) 2006-03-14 2007-09-20 Spherical Dynamics, Inc. System for and method for psychological assessment
CN103356710A (zh) * 2007-02-12 2013-10-23 人类起源公司 利用胎盘干细胞治疗炎性疾病
PT103843B (pt) * 2007-10-04 2008-08-12 Medinfar Produtos Farmaceutico Método de isolamento de células precursoras a partir do cordão umbilical humano
EP2375907B1 (en) * 2008-11-21 2019-02-27 Celularity, Inc. Treatment of diseases, disorders or conditions of the lung using placental cells
CN101748096B (zh) 2008-12-17 2013-03-13 北京汉氏联合生物技术有限公司 亚全能干细胞、其制备方法及其用途
CA2756670A1 (en) 2009-03-26 2010-09-30 The Regents Of The University Of California Mesenchymal stem cells producing inhibitory rna for disease modification
MX337480B (es) 2009-09-23 2016-03-08 Davinci Biosciences Llc Celulas madre del revestimiento de cordon umbilical y metodos y material para aislar y cultivar las mismas.
CN101890050B (zh) 2010-07-14 2012-07-04 江苏大学 脐带间质干细胞来源膜性囊泡及其应用
EP2540819A1 (en) 2011-06-27 2013-01-02 Rheinisch-Westfälische Technische Hochschule Aachen (RWTH) Method for cultivating cells in platelet-lysate-containing medium
US20210355437A1 (en) 2015-09-02 2021-11-18 Restem Llc Factor rich product from umbilical cord mesenchymal stem cells

Similar Documents

Publication Publication Date Title
MY177970A (en) Bcma (cd269/tnfrsf17) -binding proteins
BR112013012555A2 (pt) peptídeos imunogênicos para o uso na prevenção e/ou no tratamento de doenças infecciosas, doenças autoimunes, respostas imunes a alofatores, doenças alérgicas, tumores, rejeição a enxertos e respostas imunes contra vetores virais usados para a terapia de genes ou na vacinação de genes
IL255752B (en) Compounds, pharmaceutical compositions comprising the same and uses thereof for treating cardiovasclar disease, an inflammatory disease or cancer
UA130113C2 (uk) Мутеїн інтерлейкіну-21
CY1121310T1 (el) Χρηση πυριτικου ζιρκονιου για τη θεραπεια της υπερκαλιαιμιας
EA201270713A1 (ru) Белки на основе фибронектина с каркасными доменами, которые связывают ил-23
EA201390772A1 (ru) Новые соли и полиморфные формы афатиниба
DOP2006000162A (es) Nuevos anticuerpos anti-madcan
WO2013185112A8 (en) Pharmaceutical compositions for the treatment of cftr -mediated disorders
EA201000644A1 (ru) Антитела для лечения и профилактики болезни альцгеймера и их применение
EA201201661A1 (ru) Новые аминопиразолохиназолины
EP3453723A3 (en) Anti-asic1 antibodies and uses thereof
EA201000424A1 (ru) Антитела к il-23
EP2987807A3 (en) Antibodies recognising phospho-tau
EA201370018A1 (ru) Составы рифаксимина и их применение
CY1118813T1 (el) Φαρμακευτικες συνθεσεις συν-κρυσταλλων τραμαδολης και κοξιμπων
DK2276485T3 (da) Anvendelse af epothilon d i behandling af tau-associerede sygdomme,herunder alzheimers sygdom
UA113609C2 (xx) Антигензв'язуючий білок, який зв'язує людський il-23
EP2308885A3 (en) Novel compounds and methods for therapy
EA201390682A1 (ru) Спирооксиндольные антагонисты mdm2
MX360684B (es) Silicato de zirconio microporoso para el tratamiento de la hipercalemia.
EA201170659A1 (ru) Антитела к рецептору ii tgf-вета
IT1405793B1 (it) Molecola di u1snrna umano modificato, gene codificante per la molecola di u1snrna umano modificato, vettore di espressione includente il gene, e loro uso in terapia genica
IN2015DN02729A (enExample)
AR079114A1 (es) Proteinas de enlace de antigenos anti-orai1 y usos de las mismas